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CRINKLING OF EPICARDIAL 
DEFIBRILLATOR PATCHES 
A common and serious 
problem 
The durability and reliability of the implantable cardioverter-defibrillator 
epicardial patch systems have not been reported. In 128 consecutive 
patients uch systems manufactured byCardiac Pacemakers, Inc. (St. Paul, 
Minn.) or Medtronic, Inc. (Minneapolis, Minn.) were implanted with 100% 
follow-up to investigate the rate of patch crinkling and its consequences. A 
total of 122 patients urvived the operation (operative mortality, 6patients; 
4.7%). Ninety-four patients received Cardiac Pacemakers, Inc. AICD 
patches and 28 received Medtronic PCD patches. Patients had chest x-ray 
studies every 3 to 6 months and function of the defibrillator was checked 
every 3 months. Late mortality occurred in 17 patients (13%) leaving a total 
of 105 long-term survivors (82%) to the present. Among 122 survivors, 
severe crinkling of the patches occurred in 48 patientsm33 in the Cardiac 
Pacemakers, Inc. AICD group (36%) and 15 in the PCD group (54%)-- 
within 2 years of the implant. Crinkling of patches caused not only 
malfunction of the system, but also cardiac pain in three patients. 
Crinkling occurred as early as 2 months after implant and progressed 
throughout the period of observation. Fourteen patients later required 
implant of an additional transvenous defibrillator because of failure of the 
epicardial system. The percentage oftransvenous implantable cardioverter- 
defibrillator systems needed was higher for the Medtronic group (28%) 
than for the Cardiac Pacemakers, Inc. AICD group (6.3%). Both systems 
have shown an unacceptably high rate of patch crinkling that occurs in a 
relatively short time. There is no difference whether a thoracotomy or 
midline sternotomy is used or whether the patches are implanted intra- 
pericardially or extrapericardially. The quest should continue for a better 
patch system design. (J THORAC CARDIOVASC SURG 1995;110:258-64) 
J. Ernesto Molina, MD, PhD, David G. Benditt, MD, and Stuart Adler, MD, 
Minneapolis, Minn. 
T he use of implantable cardioverter-defibrillators (ICDs) has become the treatment of choice for 
life-threatening ventricular tachyarrhythmias. From 
1982 until late 1991, the standard implantable sys- 
tem entailed the use of epicardial patches that had 
to be positioned around the heart. The electrical 
discharge was delivered through these patches. All 
the implantable units were manufactured byCardiac 
Pacemakers, Inc. (CPI) (St. Paul, Minn.). During 
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the 1980s the CPI system consisted of semirigid 
patches of a titanium mesh embedded in a clear 
plastic square design. This design has remained 
unchanged and thus provides for a Consistent, long 
follow-up of the fate of these patches for more than 
JO years. 
In 1990, the Medtronic PCD unit (Medtronic, 
Inc., Minneapolis, Minn.) became available with a 
different ype of patch. Most reports on the durabil- 
ity and stability of the defibrillation threshold have 
looked at the CPI-AICD system 1-6 and have mainly 
assessed its function. 5-7 The report by Goodman and 
associates 8 is the only one in the literature on the 
fate of the defibrillator patches that showed major 
crinkling: a complication that is noted only if fol- 
low-up pays attention to it over a sufficient period of 
time. Other reports of isolated cases have indicated 
a relatively low crinkling rate, 5' 6, 9, lO but none has 
investigated the true frequency of crinkling beyond 
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anecdotal cases. 5'1t Moreover, no reports have 
looked into the crinkling rate of the Medtronic 
patch system: 
Crinkling in epicardial patches eventually will 
affect the function of  the ICD system and require 
further surgical intervention. 
In 1987 our institution started implanting A ICD 
systems manufactured by CPI; since 1989 we have 
also used the PCD Medtronic system. Because of 
the strict and meticulous follow-up that our patients 
must have, we noticed that a significant number of  
the epicardial patches showed crinkling on radio- 
graphic examination. The defibrillation thresholds 
sometimes changed to the point that the system no 
longer functioned, prompting either the addition of  
new leads or the implant of an entire new system. 
Because more epicardial patches have been im- 
planted since the Medtronic system was released for 
general use, we decided to investigate how reliable 
and safe the patch designs are. 
Patients and methods 
Since 1987, 128 patients have received an epicardial 
ICD implant system at the University of Minnesota for 
either ventricular tachycardia (n = 68) or ventricular 
fibrillation sudden death (n = 60). We used patches from 
two manufacturers: 99 patients received the CPI-AICD 
and 29 the Medtronic PCD. 
To implant hese patches we used a left thoracotomy in 
95 patients and a midline sternotomy in 33 patients. Of 
the patients undergoing midline sternotomy, nine had 
other procedures done simultaneously: six coronary artery 
bypass operation and three mitral valve operation. In the 
coronary artery bypass group, three patients underwent 
implant of the patch only at the time of the aorta-coronary 
bypass operation; these patients returned later to have the 
pulse generator implanted and the entire system tested. 
All three patients who underwent mitral valve operation 
had the patches implanted at the same time; all three 
returned later to have the pulse generator implanted. 
The operative mortality rate was 4.7% (n =~ 6). A total 
of 122 survivors were followed up for 3 months to 6 years. 
Assessment of the degree of crinkling. The patches as 
supplied by the company are fiat and straight, but as they 
are applied on the surface of the heart they adapt to 
follow the contour of the organ. Therefore a mild degree 
of curving or folding is accepted as normal. Usually we 
considered the patch normal as long as the curvature was 
not less than 160 degrees and followed the outline of the 
heart. Mild crinkling was defined as a curvature between 
160 and 135 degrees, a moderate crinkling was curvature 
between 90 and 135 degrees, and severe crinkling was any 
curvature sharper than a 90-degree angle. 9 
Crinkling occurred on various portions of the patch 
throughout follow-up. We were usually not concerned 
with the function of the system unless crinkling was 
severe, in which case we monitored the system more often 
Table I. Epicardial ICD systems 
No. 
CPI-AICD 
Two-patch 99 
Medtronic-PCD 
Two-patch 13 
Three-patch 16 
Tota! 29 
Total 128 
(every 6 months) until the patch remained unchanged for 
12 months and then every 12 months. 
Follow-up. We obtained 100% follow-up by contacting 
patients directly by phone or mail or through their private 
physicians or cardiologists. 
Once the patient was contacted, chest x-ray films were 
obtained and the degree of patch crinkling assessed. We 
then made recommendations to the patients to repeat he 
roentgenography at certain intervals, depending on the 
degree of crinkling: the interval for severe crinkling was 
every 6 months; for mild or moderate crinkling it was 
every 12 months. All x-ray films were reviewed at the 
University of Minnesota to ensure uniform comparison. 
Five patients did not receive the defibrillator at the 
University of Minnesota, but were being followed up by us 
and were thus entered into this study. 
Technique of implantation. The 128 patients under- 
went either a left thoracotomy or a midline sternotomy. 
The patches were secured to the pericardium with inter- 
rupted stitches. The number of stitches varied from six to 
eight, and they were usually placed at the edges of the 
patch to the pericardium once the proper position was 
achieved. In the two-patch system, a large size patch over 
the left ventricle was positioned lengthwise along the left 
border of the heart, with the cardiac border in the middle 
of the patch. The connecting end usually was oriented 
toward the apex, but in a few cases was oriented toward 
the base of the heart. The anterior patch was usually 
attached with six or more stitches to the pericardium 
overlying the right ventricle, with the length of the patch 
oriented from the right border of the heart toward the 
pulmonary outflow tract. 
The pericardium was closed with a few interrupted 
stitches. Enough space was left for the pericardial f uid to 
drain into the pleural cavity where the chest ube drainage 
system was implanted. The sensing electrodes were placed 
over the left ventricle. We exclusively used the sutureless 
screw-type design (CPI model 21312, Medtronic model 
6917). 
All leads were tunneled own along the rectus muscle 
sheath into the left flank of the abdomen where a pocket 
was made in the subcutaneous ti sue. 
Patches studied. We studied only the two systems 
manufactured by CPI and Medtronic because they were 
the only types implanted at the University of Minnesota 
between 1987 and 1994. In addition, four patients were 
added to our follow-up group who had not originally 
undergone implantation at our institution: we had the 
2 6 0 Molina, Benditt, Adler 
The Journal of Thoracic an 
Cardiovascular Surgel 
July 199 
Table II. Fate of epicardial ICD patches 
Severe Mild, 
crinkling moderate 
N No. % No. % Toml (%) 
PCD 28 15 54 5 18 71 
AICD 94 33 36 5 5.3 40 
Total 122 48 39 10 8 47 
original reports on these patients and all had received the 
CPI system. 
A total of 29 patients received the Medtronic system: 13 
received a two-patch system and 16 received a three-patch 
system (Table I). When three patches were used, the third 
patch was implanted on the inferior surface of the heart 
over the dome of the diaphragm: the left patch over the 
left ventricle was moved more anteriorly over the antero- 
lateral wall of the left ventricle, and the right patch 
remained inthe same position over the right anterior wall 
of the right ventricle. 
Results 
Length of follow-up. Because the CPI system had 
been used for a longer period (1987 to 1994), the 
length of follow-up extended to 61/2 years. For the 
Medtronic system (1989 to 1994), the longest fol- 
low-up was 4 years. The mean follow-up for both 
systems combined was 3.8 years. 
Mortality and morbidity. Within 6 weeks after 
the operation, six patients (4.7%) died, all of heart 
failure. The ejection fraction ranged from 0.14 to 
0.20 (estimated by preoperative two-dimensional 
echocardiographic examination). In fact, two pa- 
tients needed inotropic drug infusion during opera- 
tion to maintain adequate blood pressure after they 
underwent from four to seven induced episodes of 
ventricular fibrillation and defibrillation with use of 
the external system. 
Other complicating factors in these six patients 
were renal failure, respiratory insufficiency, and 
inability to be weaned off the respirator after gen- 
eral anesthesia. In three of them, the isoenzyme 
creatine kinase MB fraction was elevated, which 
suggests some myocardial damage during the testing. 
Of the 122 survivors, 17 later died during fol- 
low-up (13%), leaving a total of 105 long-term 
survivors (82%). Of the 17 late deaths, three were 
not witnessed and the cause is unknown. Failure of 
the defibrillator system was suspected in two of 
these patients because the threshold had changed 
throughout follow-up. In two of these patients, the 
defibrillator system was removed at their request 
with full knowledge of the risks involved; both die, 
3 months later, probably of arrhythmia. 
Of the 128 total patients, 18 had complication 
after the operation, including three who had infec 
tions that necessitated removal of the ICD systen~ 
Constrictive pericarditis occurred in two patient~ 
whose patches were removed and converted to 
transvenous system with a chest-wall patch. Hema 
tomas developed in another two patients. Two pa 
tients underwent reexploration because of bleeding 
which in one case was caused by dehiscence of th, 
patch from the cardiac surface. Another patient ha~ 
a pulmonary embolism, but recovered. 
Crinkling of epicardial patches. The degree o 
crinkling shown on chest x-ray films before radio 
graphic examination was analyzed independently fo 
the PCD and AICD systems. We classed 48 patient~ 
as having severe crinkling: 15 with the PCD and 3! 
with the AICD. Moderate crinkling was determine( 
in 10 patients. Table II shows the distribution o
crinkling for the two systems tested. 
For the 23 patients who died during follow-up, th~ 
rate of crinkling was also assessed by review of th~ 
x-ray films taken immediately before their death 
Four patients (17%) had severely crinkled patches 
Two had mild to moderate deformity (7%), and th( 
remaining 17 patients had no crinkling of th~ 
patches. On average, severe crinkling occurred aftel 
1 year and 8 months (range, 1 month to 4 years) 
The transition from mild/moderate o severe crin 
kling was rather apid. Thus in some patients who 
had roentgenographic examinations every 6 month, 
crinkling was already severe by the time of the nexl 
examination. Once crinkling appeared, it steadil) 
progressed. Fig. I shows the progression ofcrinklin~ 
in a patient with CPI patches followed up at regulal 
intervals: at 2 years the crinkling is obviously severe 
We noted a difference in the rate of crinklin~ 
between the AICD and PCD systems. In the latter 
the crinkling appeared much sooner and was more 
severe (Fig. 2, A and B). Both patients hown in 
Figs. 1 and 2 required implantation of a new trans- 
venous ystem. 
Of the 28 patients with PCD patches, 20 (71%) 
had crinkling (mild, moderate, or severe) (Table II). 
Of the 94 patients with AICD patches, 33 had severe 
crinkling and 5 mild to moderate crinkling, for a rate 
of 40%. Thus the AICD system performed better, 
especially considering that follow-up was longer and 
the number of patients was larger. 
Placing the patch extrapericardially, as was done 
for some patients, did not solve the crinkling prob- 
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Fig. 1. Crinkling of CPI-AICD patch system at 2 years. A, Posteroanterior view. Outline of patch can be 
seen on left border of heart. B, Lateral view showing severe degree of crinkling of posterolateral patch. 
lem. Fig. 3 shows a posterior patch implanted extra- 
pericardially that had the same crinkling rate as 
its intrapericardial counterparts. As follow-up 
lengthened, the patch not only crinkled more, but 
also migrated through the chest cavity. 
We found no difference between the two-patch or 
three-patch Medtronic systems. Crinkling was strongly 
associated with failure of the system to work prop- 
erly and with an increase in thresholds for defibril- 
lation effectiveness. It ultimately led to the need 
either to reoperate and use new patches or to 
implant a new transvenous defibrillator system. 
Implant of transvenous ICD. In ]4 patients, 
because of the late failure of the patch system 
(Table III) to properly defibrillate the heart, we 
implanted a new transvenous (nonthoracotomy) 
lead. All the transvenous systems used at our 
institution were Transvene-PCD (Medtronic) 
types. Table IV displays the number of patients 
who eventually required a transvenous ystem 
because of malfunctioning of the epicardial type. 
The percentage was significantly higher for the 
Medtronic PCD system (28%) versus the CPI- 
AICD system (6.3%). 
Other complications. In addition to failure to 
defibrillate, crinkling of the patches also caused 
cardiac pain in several patients. At least three 
patients who needed reoperation had pain: in two 
reoperation was done because of a cardiac ondition 
unrelated to the ICD and directly related to the 
crinkling. 
A 24-year-old woman with Marfan's syndrome 
previously had an epicardial Medtronic patch sys- 
tem; severe mitral regurgitation developed for which 
mitral valve replacement was recommended. She 
had frequently reported cardiac pain that occurred 
unpredictably, day or night, and was not related to 
any specific activity. Severe crinkling of her PCD 
patches had developed but the unit was still working. 
Because she was young and the coronary arterio- 
gram was perfectly normal, we concluded that the 
cause of the pain was probably the crinkled poste- 
rior patch located between the inferior surface of 
the heart and the diaphragm. At the time of mitral 
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Fig. 2. Gradual crinkling of PCD patch system. A,Lateral view attime of implant. B, Lateral view ofsame 
patient 9 months later. Severe crinkling of both patches can be o served. 
Table III. Transvenous ICD implantation i  
patients with epicardial system malfunctioning 
No. % 
CPI-AICD 6 of 94 6.3 
Medtronic-PCD 8 of 28 28 
Total 14 of i22 11.5 
Fig. 3. Lateral view at 1 year after operation in patient 
who underwent implant of PCD patch system extraperi- 
cardially. Extrapericardial posterior patch has crinkled 
and migrated across chest cavity toward the back. 
valve replacement, we removed this patch: After 
operation the pain completely disappeared. 
/A 48-year-old man had patch crinkling in the 
Same position as the woman just described. He also 
'needed the patch removed because of infection. As 
soon as the patch was removed through a lel 
thoracotomy, the pain disappeared. 
The third patient was a heart transplant recil: 
ient whose ICD system was implanted while h 
was on the Organ waiting list. He reported cardia 
pains that were positional and distinct from th 
angina ~.His pain disappeared after the hear 
transplant. 
These three cases point to the fact that crinklin 
can cause not only inadequate function, but als 
actual injury to the heart (because of the rigidity c 
this foreign body pressing on the ventricles). 
As of May 1, 1994, 35 patients who still have th 
original, but crinkled, defibrillator patch systei 
are alive with the system adequately workint 
These patients are now being followed up perioc 
icatly for function and for worsening of th 
patch crinkling (which may become more sever 
and may also lead to migration within the che~ 
cavity). 
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Discussion 
The epicardial patch system for defibrillators i
being replaced these days by the transvenous ap- 
proach, which has less morbidity and mortality. 
However, the epicardial system will always be 
needed for certain patients, 12'13 particularly for 
those in whom adequate defibrillation thresholds 
cannot be reached with the transvenous approach, 
for children, for patients with occluded venous 
systems, for patients receiving dialysis, or for pa- 
tients with transvenous devices already implanted in 
the upper veins of the body. 
The two most common ICD epicardial patch 
systems now on the market, namely CPI and 
Medtronic, have shown an unacceptable high rate of 
patch crinkling, which occurs in a relatively short 
period. In our study, the mean value was i year and 
8 months. With the Food and Drug Administration's 
release of the Medtronic epicardial patch systems, 
more will be implanted in the future. Thus it is likely 
that the number of patients with crinkled patches 
will soon increase. Not only will the patch eventually 
fail, but it also may migrate and erode into nearby 
organs or cause pain of cardiac origin. If an intra- 
pericardial implant echnique is used, compression 
will probably be confined to the heart, but in the 
extraperieardial system the patches may migrate 
into the chest cavity or mediastinum, as we have 
seen. 
When some of these crinkled patches were 
surgically removed, the findings varied; for 
example, the suture material might have pulled 
through the pericardium or the pericardium ight 
follow the contour of the crinkled patch. In 
two patients with Medtronic system patches we 
found that stitches had pulled through the patch 
material itself. Because crinkling and folding of 
the patches has also been observed, in eases in 
which the patches were placed in the subcutane- 
ous tissue of the chest, in conjunction with im- 
plant of transvenous leads, we changed our tech- 
nique to sewing the patches with a running 
nonabsorbable suture, usually monofilament ma- 
' terial, along the entire circumference of the patch. 
However, this technique cannot be followed up in 
most of the cases when patches are placed in the 
pericardium because of the lack of sufficient ex- 
posure. Actually, even placing six interrupted 
stitches in various areas of the patch to anchor it 
to the pericardium is something quite difficult. 
Therefore most of the free edges of the patch are 
not anchored. 
Table IV. Patients who received transvenous ICD 
systems because of increased efibrillation threshold 
associated with crinkling of patch leads 
Threshold 
Patient Threshold at time Interval change 
No. of implant (joules) (mos) (joules) 
1 15 24 32+ 
2 10 24 30+ 
3 18 22 32+ 
4 15 10 30+ 
5 10 11 32+ 
6 10 40 34+ 
7 15 24 32+ 
8 15 12 32+ 
9 15 34 32+ 
10 18 19 32+ 
11 15 5 34+ 
12 10 29 34+ 
13 18 20 30+ 
14 15 10 32+ 
Mean 14.2 20.2 32+ 
Once a defibrillator system becomes ineffective, 
a new system is required, usually a transvenous 
device. Although better, transvenous devices are 
not free of complications either, lz Complications 
we have already seen include vein thrombosis of 
the subclavian veins extending into the arm and 
severe fibrotic obstruction of the innominate veins 
or superior vena cava (which also makes heart 
transplantation for those patients rather difficult 
and more risky). Perforation of the right ventricle 
by the heavier and stiffer transvenous defibrillator 
leads has caused cardiac tamponade, placing pa- 
tients at high risk, particularly those with poor 
ventricular function. Infections with endocarditis 
have also been caused by these intravascular 
devices. Migration of the floating leads in the 
superior vena cava or innominate vein is also a 
problem. 
Thus the need remains for a better epicardial 
patch system that will allow lower thresholds for 
effective defibrillation and will permit smaller pulse 
generators to be implanted in the chest. The new 
Medtronic Jewel unit, for example, is one such 
system now in clinical trials. 
Surgeons and cardiologists must be fully aware of 
all these problems. In cooperation with the medical 
device industry, they should make an effort o design 
safer systems to treat patients who already have 
marginal cardiac reserves. 
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